Daiichi Life Insurance Co. Ltd. purchased a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 8,608 shares of the conglomerate's stock, valued at approximately $6,198,000.
A number of other large investors have also modified their holdings of the stock. Sivia Capital Partners LLC boosted its holdings in Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock valued at $397,000 after purchasing an additional 119 shares during the period. First Trust Advisors LP increased its holdings in Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock worth $10,947,000 after purchasing an additional 14,217 shares during the period. Main Street Financial Solutions LLC increased its holdings in Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock worth $610,000 after purchasing an additional 886 shares during the period. Ieq Capital LLC raised its position in Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock valued at $14,957,000 after purchasing an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC boosted its stake in shares of Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock valued at $273,000 after buying an additional 325 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.
Danaher Stock Performance
Shares of DHR opened at $219.42 on Friday. The stock has a 50 day moving average price of $195.80 and a 200 day moving average price of $192.61. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $154.25 billion, a price-to-earnings ratio of 38.97, a price-to-earnings-growth ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.
Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the firm posted $0.77 earnings per share. The firm's revenue was up 5.5% on a year-over-year basis. Research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of analysts recently weighed in on DHR shares. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. Wall Street Zen lowered shares of Danaher from a "buy" rating to a "hold" rating in a report on Saturday, April 25th. Wolfe Research cut shares of Danaher from an "outperform" rating to a "peer perform" rating in a research report on Monday, June 1st. HSBC lowered their target price on shares of Danaher from $270.00 to $230.00 and set a "buy" rating for the company in a research note on Wednesday, June 3rd. Finally, Piper Sandler started coverage on Danaher in a report on Thursday, June 11th. They issued a "neutral" rating and a $200.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $228.91.
Check Out Our Latest Report on Danaher
Danaher Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
